• HAUS1 as a Prognostic Biomarker and Immune Modulator in HCC

  2026-08-06

  The referenced study reveals that HAUS1 is highly expressed in hepatocellular carcinoma (HCC) and is linked to poor prognosis, tumor progression, and immune microenvironment alterations. These findings highlight HAUS1's potential as a diagnostic, prognostic, and therapeutic target, underscoring new avenues for biomarker-driven cancer research and therapy.

• Birinapant (TL32711): Advancing Apoptosis Induction in Cance

  2026-08-05

  Birinapant (TL32711) delivers reproducible, high-sensitivity apoptosis induction by targeting IAPs, enabling advanced cancer cell modeling and translational workflows. Recent biomarker discoveries, notably around MDM1 and p53, further empower researchers to overcome therapy resistance using this potent SMAC mimetic from APExBIO.

• Cefodizime: Precision Use of a Third-Gen Cephalosporin in Re

  2026-08-05

  Explore Cefodizime’s molecular pharmacology, immunomodulatory effects, and best practices for precise assay design. This in-depth analysis delivers actionable insights for leveraging this third-generation cephalosporin antibiotic in advanced microbiology research.

• Azathramycin A: Macrolide Antibiotic Innovation in TB Models

  2026-08-04

  Azathramycin A streamlines tuberculosis research by combining potent ribosomal inhibition with workflow flexibility, enabling precise modeling of Mycobacterium tuberculosis infection and resistance mechanisms. This guide translates biophysical insights and real-world protocols into actionable steps for advanced antibiotic discovery.

• Heparin Sodium: Applied Protocols for Thrombosis and Coagula

  2026-08-04

  Heparin sodium from APExBIO empowers precise modeling of blood coagulation and thrombosis, offering high solubility and robust anti-factor Xa activity in both classic and next-generation delivery workflows. This guide translates the latest mechanistic insights and experimental innovations—like exosome-inspired nanoparticle strategies—into practical steps and troubleshooting for researchers.

• Practical Guidance for Cell Counting Kit-8 (CCK-8) Plus Assa

  2026-08-03

  Cell Counting Kit-8 (CCK-8) Plus enables sensitive, rapid assessment of cell viability and cytotoxicity, addressing common workflow bottlenecks in proliferation and drug screening experiments. It is suited for high-throughput and quantitative applications in diverse cell types, but is not designed for endpoint measurements in non-viable or metabolically inactive samples.

• CTOP: Optimizing μ-Opioid Receptor Antagonism in Pain Resear

  2026-08-03

  CTOP stands out as a selective μ-opioid receptor antagonist, empowering researchers to dissect central opioid signaling and mechanical hypersensitivity with unmatched specificity. This article details practical protocols, advanced use cases, and troubleshooting tips based on recent mechanistic breakthroughs—streamlining neuropharmacology and pain mechanism research.

• Levofloxacin: Applied Workflows for DNA Replication and Cell

  2026-08-02

  Levofloxacin, a synthetic fluoroquinolone antibiotic, delivers unmatched precision for bacterial DNA replication studies and bone/cartilage cell assays. Discover stepwise protocols, evidence-backed troubleshooting, and strategic integration for multidomain research advancement.

• Sodium Dicloxacillin Monohydrate: Precision Workflows for MS

  2026-08-01

  Sodium dicloxacillin monohydrate enables reproducible, high-sensitivity workflows for dissecting methicillin-sensitive Staphylococcus aureus (MSSA) pathogenesis in both in vitro and in vivo models. This article details protocol enhancements, troubleshooting tips, and novel assay strategies that uniquely leverage APExBIO’s high-purity β-lactam antibiotic for Gram-positive bacterial infection research.

• Antibacterial Use and Resistance in Psychiatric Hospitals Du

  2026-07-31

  This study provides a detailed, data-driven analysis of antibacterial drug use and bacterial resistance patterns in a psychiatric hospital during the COVID-19 epidemic. By comparing local, provincial, and national antibiotic use and resistance data, the research clarifies unique stewardship challenges and highlights the need for enhanced monitoring to optimize patient outcomes.

• GKT137831: Optimizing Redox Assays with a Dual Nox1/Nox4 Inh

  2026-07-31

  This article presents practical, scenario-driven guidance for integrating GKT137831 (SKU B4763) into cell viability, proliferation, and cytotoxicity assays. By addressing common laboratory challenges and referencing quantitative data, it demonstrates how this dual NADPH oxidase Nox1/Nox4 inhibitor from APExBIO enhances experimental reproducibility and specificity in oxidative stress research.

• Nuclear Export Inhibition Combos in Basal-like TNBC: Selinex

  2026-07-30

  This study systematically identified and validated nuclear export inhibitor-based combination therapies using preclinical models of triple-negative breast cancer (TNBC). Notably, KPT-330 (Selinexor) paired with a PI3K/mTOR inhibitor showed synergistic tumor suppression, advancing targeted strategies for chemoresistant TNBC.

• Entecavir (BMS200475): Optimizing HBV Replication Inhibition

  2026-07-30

  Entecavir, a potent HBV DNA polymerase inhibitor, is uniquely effective for both wild-type and lamivudine-resistant hepatitis B virus strains. This guide translates current research—including novel safety observations—into actionable protocols and troubleshooting strategies for maximizing reproducibility and translational impact in chronic hepatitis B research.

• DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution

  2026-07-29

  DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution (SKU K2402) addresses the need for rapid, reliable nuclear visualization and cell viability assessment in fixed or membrane-compromised cells. It is not suitable for live-cell imaging due to its limited membrane permeability.

• Plk1-Mediated p31comet Regulation in Mitotic Checkpoint Disa

  2026-07-29

  This study elucidates how Polo-like kinase 1 (Plk1) directly phosphorylates the Mad2-binding protein p31comet, suppressing its activity in disassembling mitotic checkpoint complexes—a critical step for accurate cell division. The findings clarify the molecular timing mechanisms that prevent premature checkpoint inactivation and have broad implications for cell cycle research.

16419 records 1/1095 page Next 12345 下5页 Last page